How the simplified abstract is structured
The PDF rewrites the abstract of a Danish cohort study published in Diabetes Care (DOI 10.2337/dc25-0693) into a series of labelled steps that any interested reader can follow:
- Background: what SGLT2 inhibitors do and why they might affect genital health.
- Specific background: what phimosis is and why GLP-1 receptor agonists make a suitable comparison.
- Knowledge gap: genital infections with SGLT2i are known, but long-term structural complications such as phimosis had not been studied.
- Here we show: the question the study set out to answer.
- Methodological approach: the study design in two sentences.
- Results and interpretation: the key numbers and what they mean.
- Implications: what clinicians and patients might take from the findings.
Each step answers one question, which helps readers who are not specialists in diabetes or epidemiology.
Explaining the study design in plain terms
The original paper uses methods that are standard in pharmacoepidemiology but unfamiliar to many readers. The simplified version describes them without jargon. The study used nationwide Danish registry data from 2016 to 2021 and compared men already taking metformin who started either an SGLT2 inhibitor or a GLP-1 receptor agonist. Comparing two groups who both started a new diabetes drug, rather than comparing users with non-users, reduces the risk that differences in disease severity explain the results. Inverse probability of treatment weighting was used to balance the groups on measured characteristics, which the simplified abstract describes as making the two groups comparable on factors that could otherwise distort the comparison.
Presenting risk numbers so they are not misread
The study included 32,486 men starting an SGLT2 inhibitor and 14,793 starting a GLP-1 receptor agonist, followed for a median of four years. One-year risk of phimosis was 0.9% versus 0.5% (risk ratio 1.88), and eight-year risk was 4.8% versus 3.6% (risk ratio 1.36).
Relative risks alone can sound alarming, so good lay summaries also show absolute differences. Here the difference is 0.4 percentage points at one year and 1.2 percentage points at eight years, roughly 12 additional cases per 1,000 men over eight years. Presenting both figures, and keeping the word 'associated' rather than implying proof of cause, gives a balanced picture. The original authors also note that further studies are needed to clarify causality, and the simplified abstract keeps that caveat.
Readers this summary is written for
A simplified abstract on a drug safety signal reaches several audiences at once. Men with type 2 diabetes and their families want to know whether the finding affects them. General practitioners, diabetes nurses and pharmacists want a quick, accurate summary to support conversations with patients. Journalists and health communicators need correct numbers and the right caveats. Writing for all of them means leading with the practical question, keeping the comparison drug in view so the result is not misread as a reason to stop treatment, and pointing readers to the original article for full details.
Guidance that shapes plain-language summaries
Plain-language summaries of research are increasingly requested by journals, funders and regulators. Useful references include the Good Lay Summary Practice guidance developed for the EU Clinical Trials Regulation, Cochrane's standards for plain language summaries, and publishers' own author guidance on lay summaries. Common principles are: state the main finding early, define every technical term, avoid overstating certainty, present numbers in a consistent format, and test readability with people outside the field. The sample applies these by giving each step a heading, keeping sentences short and closing with practical implications such as attention to hygiene and prompt treatment of genital infections.
This simplified abstract is a writing sample summarising published research and is not medical advice; anyone with concerns about their diabetes medication should discuss them with their doctor.
Ordering a simplified abstract for your research
Authors usually request a simplified abstract when a journal invites a lay summary, when a funder requires public-facing outputs, or when they want to share results with patients and practitioners. Pubrica's simplified abstract service prepares summaries from the published or accepted paper, checked for accuracy against the original. For a visual alternative, a graphical abstract presents the same findings as an image, and a scientific news report suits wider media audiences. Orders can be placed through the order page.